Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of a MEK inhibitor, NFX-179, as a chemoprevention agent for squamous cell carcinoma.
Sarin KY, Kincaid J, Sell B, Shahryari J, Duncton MAJ, Morefield E, Sun W, Prieto K, Chavez-Chiang O, de Moran Segura C, Nguyen J, Bronson RT, Plotkin SR, Kochendoerfer GG, Fenn P, Wootton MA, Powala C, de Souza MP, Tsai KY. Sarin KY, et al. Sci Transl Med. 2023 Oct 11;15(717):eade1844. doi: 10.1126/scitranslmed.ade1844. Epub 2023 Oct 11. Sci Transl Med. 2023. PMID: 37820007
Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes.
Ko JS, Matharoo-Ball B, Billings SD, Thomson BJ, Tang JY, Sarin KY, Cai E, Kim J, Rock C, Kimbrell HZ, Flake DD 2nd, Warf MB, Nelson J, Davis T, Miller C, Rushton K, Hartman AR, Wenstrup RJ, Clarke LE. Ko JS, et al. Among authors: sarin ky. Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):1107-1113. doi: 10.1158/1055-9965.EPI-16-0958. Epub 2017 Apr 4. Cancer Epidemiol Biomarkers Prev. 2017. PMID: 28377414
A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations.
Pastorino S, Yoshikawa Y, Pass HI, Emi M, Nasu M, Pagano I, Takinishi Y, Yamamoto R, Minaai M, Hashimoto-Tamaoki T, Ohmuraya M, Goto K, Goparaju C, Sarin KY, Tanji M, Bononi A, Napolitano A, Gaudino G, Hesdorffer M, Yang H, Carbone M. Pastorino S, et al. Among authors: sarin ky. J Clin Oncol. 2018 Oct 30;36(35):JCO2018790352. doi: 10.1200/JCO.2018.79.0352. Online ahead of print. J Clin Oncol. 2018. PMID: 30376426 Free PMC article.
From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB).
Eichstadt S, Tang JY, Solis DC, Siprashvili Z, Marinkovich MP, Whitehead N, Schu M, Fang F, Erickson SW, Ritchey ME, Colao M, Spratt K, Shaygan A, Ahn MJ, Sarin KY. Eichstadt S, et al. Among authors: sarin ky. Clin Cosmet Investig Dermatol. 2019 Dec 24;12:933-942. doi: 10.2147/CCID.S232547. eCollection 2019. Clin Cosmet Investig Dermatol. 2019. PMID: 31920360 Free PMC article.
Familial skin cancer syndromes: Increased melanoma risk.
Ransohoff KJ, Jaju PD, Tang JY, Carbone M, Leachman S, Sarin KY. Ransohoff KJ, et al. Among authors: sarin ky. J Am Acad Dermatol. 2016 Mar;74(3):423-34; quiz 435-6. doi: 10.1016/j.jaad.2015.09.070. J Am Acad Dermatol. 2016. PMID: 26892652 Review.
Molecular profiling to diagnose a case of atypical dermatomyositis.
Sarin KY, Chung L, Kim J, Higgs BW, Jallal B, Yao Y, Fiorentino DF. Sarin KY, et al. J Invest Dermatol. 2013 Dec;133(12):2796-2799. doi: 10.1038/jid.2013.240. Epub 2013 Jun 3. J Invest Dermatol. 2013. PMID: 23732751 Free article. No abstract available.
127 results